Pharmaceutical and Life Sciences
Helping to Drive Growth with Industry Expertise
Drug pipelines and R&D spend continue to shrink, growth has shifted overseas, generics continue to increase competitive pressure, and the regulatory environment continues to evolve. The SC&H Group teams are experts in the regulatory issues and the sensitive nature of the pharmaceutical and life sciences industry. We have advised industry leaders with the expertise, resources, and relationships that solve today’s market challenges, drive growth, and enhance revenue.
- Bio-technology companies
- Medical device companies
- Pharmaceutical companies
- Life science-related R&D companies
- Health service providers
- Life science support companies
- Recovered non-compliant vendor charges totaling $5.7 million, roughly 6% of total spend, during the contract compliance audit period.
I need help with: